Study of Effects of L-Arginine in Colitis and Colon Cancer
- Conditions
- Colon CancerUlcerative Colitis
- Registration Number
- NCT01091558
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
The purpose of this study is to look at the importance of L-Arginine in the digestive tract. L-Arginine is an amino acid and is important in making proteins within the cell.
The evaluation of colon tissue, blood, urine, diet, health history, and symptoms will help us learn more about L-Arginine and ulcerative colitis. The investigators believe these studies will provide new insights into the treatment for Inflammatory Bowel Disease (ulcerative colitis) and nutritional needs. The investigators plan to enroll 200 participants in this study over the next two years.
- Detailed Description
Amino acids are being measured in colon tissues and in serum by high performance liquid chromotography (HPLC). Cytokines and chemokines are being measured in colon tissues and in serum by Luminex assay. Cytokines and chemokines are also being measured in colon tissues by real-time polymerase chain reaction (PCR) analysis of mRNA expression.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 204
- 18 years of age or older
- Colonoscopy for one of the following: clinical indications, disease assessment, or surveillance for dysplasia (as in ulcerative colitis)
- Screening for cancer
- refusal to participate
- age less than 18 years at time of colonoscopy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method L-Arginine (L-Arg) availability in ulcerative colitis (UC) patients and normal control subjects, and correlate with disease activity 24 months
- Secondary Outcome Measures
Name Time Method L-Arg intake in the diet of UC patients and control subjects 24 months
Trial Locations
- Locations (1)
Vanderbilt Hospital
🇺🇸Nashville, Tennessee, United States